US Map / Ohio
State OH

Clinical Trials in Ohio

Ohio is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Ohio and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 522 actively recruiting studies with Ohio sites out of 522 registered in total. The busiest research areas in Ohio are Prostate Cancer, Breast Cancer, Ovarian Cancer. Leading sponsors running trials in the state include Ohio State University, Children's Hospital Medical Center, Cincinnati, National Cancer Institute (NCI). By stage, Ohio trials break down as Phase 1 (98), Phase 2 (162), Phase 3 (125), Phase 4 (23).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
522
Recruiting Now
522
← Back to US Map
Top Conditions in Ohio
Prostate Cancer (9)Breast Cancer (9)Ovarian Cancer (8)Endometrial Cancer (7)Acute Myeloid Leukemia (6)Solid Tumor (6)Pancreatic Cancer (5)Heart Failure (5)Multiple Myeloma (5)Colorectal Cancer (5)Advanced Solid Tumor (5)Stroke (5)

Frequently Asked Questions — Clinical Trials in Ohio

How many clinical trials are currently recruiting in Ohio?
ClinicalMetric currently tracks 522 actively recruiting clinical trials with at least one location in Ohio. The total number of registered studies—including active but not currently enrolling trials—is 522. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Ohio?
Ohio hosts clinical trials across a broad range of medical conditions, including Prostate Cancer, Breast Cancer, Ovarian Cancer, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Ohio serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Ohio?
To join a clinical trial in Ohio, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Ohio maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Ohio

NCT05110989 N/A
Recruiting
A Multicenter Patient Registry on Outcomes From Cryoanalgesia of the Intercostal...
Condition
Post Operative Pain
Enrollment
5,000 pts
Location
United States, Austria, Belgium
Sponsor
AtriCure, Inc.
View Trial →
NCT05725928 N/A
Recruiting
Assisted Ambulation to Improve Health Outcomes for Older Medical Inpatients
Condition
Mobility Limitation
Enrollment
3,000 pts
Location
United States
Sponsor
The Cleveland Clinic
View Trial →
NCT06091865 Phase 3
Recruiting
A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and Ho...
Condition
Diffuse Large B-cell Lymphoma (DLBCL)
Enrollment
904 pts
Location
United States, Australia, Austria
Sponsor
Regeneron Pharmaceuticals
View Trial →
NCT04747236 Phase 2
Recruiting
Randomized Phase IIB Trial of Oral Azacytidine Plus Romidepsin Versus Investigat...
Condition
PTCL
Enrollment
50 pts
Location
United States
Sponsor
University of Virginia
View Trial →
NCT06959511 Phase 2
Recruiting
Zanzalintinib for the Treatment of Advanced Thyroid Cancer Before Surgery
Condition
Neoadjuvant Treatment
Enrollment
45 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
View Trial →
NCT07845487 Phase 2
Recruiting
A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately ...
Condition
Ulcerative Colitis (UC)
Enrollment
204 pts
Location
United States, Canada, Czechia
Sponsor
Palisade Bio
View Trial →
NCT07296484 Phase 2
Recruiting
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
Condition
Type 2 Diabetes
Enrollment
1,500 pts
Location
United States
Sponsor
Sparrow Pharmaceuticals
View Trial →
NCT06836232 Phase 2
Recruiting
An Open-Label Pilot Study of VTX2735 in Recurrent Pericarditis
Condition
Recurrent Pericarditis
Enrollment
50 pts
Location
United States, Belgium, Canada
Sponsor
Zomagen Biosciences Ltd.
View Trial →
NCT06783309 Phase 1, Phase 2
Recruiting
CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Wit...
Condition
Type 1 Diabetes Mellitus
Enrollment
72 pts
Location
United States
Sponsor
COUR Pharmaceutical Developmen
View Trial →
NCT05429632 Phase 3
Recruiting
Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Al...
Condition
Adult Acute Myeloid Leukemia
Enrollment
366 pts
Location
United States, Argentina, Brazil
Sponsor
Priothera SAS
View Trial →
NCT07378644 Phase 2, Phase 3
Recruiting
Study to Evaluate the Pharmacodynamics, Safety and Efficacy of SKY-0515 in Parti...
Condition
Huntington Disease
Enrollment
400 pts
Location
United States, Argentina, Brazil
Sponsor
Skyhawk Therapeutics, Inc.
View Trial →
NCT07444814 Phase 1
Recruiting
Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Dr...
Condition
Endometrial Cancer
Enrollment
226 pts
Location
United States
Sponsor
Whitehawk Therapeutics, Inc.
View Trial →
NCT06401421 N/A
Recruiting
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Brea...
Condition
Breast Cancer
Enrollment
1,800 pts
Location
United States, Canada
Sponsor
Exact Sciences Corporation
View Trial →
NCT03533816 Phase 1
Recruiting
Expanded/Activated Gamma Delta T-cell Infusion Following Hematopoietic Stem Cell...
Condition
Acute Myeloid Leukemia
Enrollment
38 pts
Location
United States
Sponsor
University of Kansas Medical C
View Trial →
NCT06502171 Phase 1
Recruiting
Study of Cabozantinib With Selumetinib for Plexiform Neurofibromas
Condition
Neurofibromatosis 1
Enrollment
30 pts
Location
United States
Sponsor
Girish Dhall, MD
View Trial →
NCT06753916 Phase 2
Recruiting
ExCrossV Multi Site Trial for Vascularized High Risk Keratoplasty
Condition
Corneal Transplant Failure
Enrollment
96 pts
Location
United States
Sponsor
Massachusetts Eye and Ear Infi
View Trial →
NCT06298916 Phase 1, Phase 2
Recruiting
64Cu-LNTH-1363S in Patients With Sarcoma or Gastrointestinal Tract Cancer
Condition
Metastatic Sarcoma
Enrollment
26 pts
Location
United States
Sponsor
Lantheus Medical Imaging
View Trial →
NCT07024316 Phase 1, Phase 2
Recruiting
A Study to Investigate the Improvement of Photosensitivity in Terms of Skin Lesi...
Condition
Congenital Erythropoietic Porphyria (CEP)
Enrollment
6 pts
Location
United States
Sponsor
Atlas Molecular Pharma
View Trial →
NCT05419492 Phase 1, Phase 2
Recruiting
A Clinical Study to Evaluate the Safety and Efficacy of ETX101 in Infants and Ch...
Condition
Dravet Syndrome
Enrollment
113 pts
Location
United States, Australia, United Kingdom
Sponsor
Encoded Therapeutics
View Trial →
NCT05267821 Phase 2, Phase 3
Recruiting
Targeted Reversal of Inflammation in Pediatric Sepsis-induced MODS
Condition
Pediatric Sepsis-induced Multiple Organ Dysfunction Syndrome (MODS)
Enrollment
500 pts
Location
United States
Sponsor
Nationwide Children's Hospital
View Trial →
NCT06568367 Phase 3
Recruiting
Studying Solriamfetol Modulation of TAAR-1, Dopamine, and Norepinephrine in Shif...
Condition
Excessive Sleepiness
Enrollment
520 pts
Location
United States, Canada
Sponsor
Axsome Therapeutics, Inc.
View Trial →
NCT06909565 Phase 4
Recruiting
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and...
Condition
Percutaneous Coronary Intervention
Enrollment
6,000 pts
Location
United States
Sponsor
Duke University
View Trial →
NCT01587300 N/A
Recruiting
Neuroblastoma Biology Study
Condition
Neuroblastoma
Enrollment
1,000 pts
Location
United States, Canada
Sponsor
New Approaches to Neuroblastom
View Trial →
NCT05645107 Phase 3
Recruiting
A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatm...
Condition
Hypogammaglobulinemia
Enrollment
386 pts
Location
United States, Bosnia and Herzegovina, Bulgaria
Sponsor
Grifols Therapeutics LLC
View Trial →
NCT05521698 Phase 1
Recruiting
A Randomized Trial of Bicalutamide in Non-Muscle Invasive Bladder Cancer
Condition
Non-Muscle Invasive Bladder Urothelial Carcinoma
Enrollment
80 pts
Location
United States
Sponsor
University of Wisconsin, Madis
View Trial →
Page 15 of 21 — 522 trials total
← Prev Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology